Advances in the treatment of refractory mycoplasma pneumoniae pneumonia in children with different doses of glucocorticoids / 国际儿科学杂志
International Journal of Pediatrics
;
(6): 792-795, 2020.
Article
Dans Chinois
| WPRIM
| ID: wpr-863068
ABSTRACT
Mycoplasma pneumoniae is one of the most common pathogens in children with community-acquired pneumonia.Some cases of mycoplasma pneumoniae pneumonia may develop into refractory mycoplasma pneumoniae pneumonia(RMPP). Glucocorticoid therapy can delay the disease and shorten the hospital stay, which is an effective method for the treatment of children with RMPP.This paper reviews the progress of glucocorticoids in the treatment of RMPP in children.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
langue:
Chinois
Texte intégral:
International Journal of Pediatrics
Année:
2020
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS